PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models

• Gaia Zuccolotto,

  Affiliation Department of Medicine, University of Padua, Padua, Italy

  ⨯
• Giulio Fracasso,

  Affiliation Department of Pathology and Diagnostics, Section of Immunology, University of Verona, Verona, Italy

  ⨯
• Anna Merlo,

  Affiliation Veneto Institute of Oncology IOV - IRCCS, Padua, Italy

  ⨯
• Isabella Monia Montagner,

  Affiliation Veneto Institute of Oncology IOV - IRCCS, Padua, Italy

  ⨯
• Maria Rondina,

  Affiliation Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy

  ⨯
• Sara Bobisse,

  Affiliation Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland

  ⨯
• Mariangela Figini,

  Affiliation Molecular Therapies Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  ⨯
• Sara Cingarlini,

  Affiliation Medical Oncology, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy

  ⨯
• Marco Colombatti,

  Affiliation Department of Pathology and Diagnostics, Section of Immunology, University of Verona, Verona, Italy

  ⨯
• Paola Zanovello,

  Affiliations Veneto Institute of Oncology IOV - IRCCS, Padua, Italy, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy

  ⨯
• Antonio Rosato

  * E-mail: antonio.rosato@unipd.it

  Affiliations Veneto Institute of Oncology IOV - IRCCS, Padua, Italy, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy

  ⨯